Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
Farmers Insurance

Generated: June 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040564

« Back to Dashboard

NDA 040564 describes DOXYLAMINE SUCCINATE, which is a drug marketed by Copley Pharm, LNK, Perrigo, Quantum Pharmics, Actavis Labs Fl Inc, and Par Pharm Inc, and is included in six NDAs. It is available from twenty-eight suppliers. Additional details are available on the DOXYLAMINE SUCCINATE profile page.

The generic ingredient in DOXYLAMINE SUCCINATE is doxylamine succinate; pyridoxine hydrochloride. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the doxylamine succinate; pyridoxine hydrochloride profile page.
Summary for 040564
Ingredient:doxylamine succinate
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 040564
Suppliers and Packaging for NDA: 040564
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DOXYLAMINE SUCCINATE doxylamine succinate TABLET;ORAL 040564 ANDA Rite Aid Corporation 11822-0386 N 11822-0386-2
DOXYLAMINE SUCCINATE doxylamine succinate TABLET;ORAL 040564 ANDA Better Living Brands, LLC 21130-386 N 21130-386-22

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength25MG
Approval Date:Aug 27, 2004TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Express Scripts
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.